SMTL ID : 3drs.1

HIV reverse transcriptase K103N mutant in complex with inhibitor R8D

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 3.15 Å

Oligo State

hetero-1-1-mer

Ligands

1 x R8D: 3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile(Non-covalent)

R8D.1: 17 residues within 4Å: Chain A: L.103, K.104, K.105, N.106, K.107, V.109, V.111, V.182, Y.184, Y.191, G.193, P.228, F.230, L.237, H.238, P.239, Y.321 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.103, A:V.109, A:V.109, A:Y.184, A:P.228, A:P.239 Hydrogen bonds: A:N.106, A:N.106 pi-Stacking: A:Y.191

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Tucker, T.J. et al., Discovery of 3-{5-[(6-Amino-1H-pyrazolo[3,4-b]pyridine-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile (MK-4965): A Potent, Orally Bioavailable HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor with Improved Potency against Key Mutant Viruses. J.Med.Chem. (2008)

Release Date

2008-10-14

Peptides

Reverse transcriptase/ribonuclease H: A
p66 RT: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Reverse transcriptase/ribonuclease H

p66 RT

Related Entries With Identical Sequence